angiotensin ii has been researched along with 15-hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic acid in 100 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 10 (10.00) | 18.7374 |
1990's | 42 (42.00) | 18.2507 |
2000's | 38 (38.00) | 29.6817 |
2010's | 10 (10.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chibana, T; Matsuzaki, T; Noguchi, K; Ojiri, Y; Sakanashi, M | 1 |
Angus, JA; Jennings, GL; Sudhir, K | 1 |
Farhat, MY; Ramwell, PW | 1 |
McGiff, JC; Quilley, J | 1 |
Arendshorst, WJ; Chatziantoniou, C; Daniels, FH | 1 |
Armstead, WM; Hyman, AL; Kadowitz, PJ; Lippton, HL | 1 |
Hyman, AL; Kadowitz, PJ; Lippton, HL | 1 |
Allen, GT; Heran, CL; Ogletree, ML; Schumacher, WA | 1 |
Adkinson, NF; Crowley, K; Gurtner, GH; McShane, AJ; Michael, JR; Shayevitz, JR; Traystman, RJ | 1 |
Zimmerman, BG | 1 |
Trachte, GJ | 1 |
Mistry, M; Nasjletti, A | 1 |
Elder, MG; Glance, DG; Myatt, L | 1 |
Gordon, JL; Martin, W | 1 |
Dutton, J; Forster, C; Lye, R; Paul, KS; Whalley, ET | 1 |
Bult, H; De Meyer, GR; Herman, AG; Jordaens, FH; Kockx, M; Ustünes, L; Zonnekeyn, LL | 1 |
Bascands, JL; Bompart, G; Girolami, JP; Pecher, C; Rakotoarivony, J; Tack, JL | 1 |
Feng, CJ; Ibrahim, IN; Kadowitz, PJ; Kaye, AD; Nossaman, BD | 1 |
Garrison, EA; Kadowitz, PJ; Osei, SY; Santiago, JA | 1 |
Grimminger, F; Seeger, W; Spriestersbach, R; Walmrath, D; Weissmann, N | 1 |
Bertolino, F; Bessac, AM; John, GW; Jover, B; Maffre, M; Valentin, JP | 2 |
Fulton, JD; Howie, KA; MacDonald, E; McDonald, A; Scott, PJ; Wadsworth, RM | 1 |
Bolofo, ML; MacLennan, SJ; Martin, GR | 1 |
Bell-Quilley, CP; Drugge, ED; Hilchey, SD; Lin, YS; McGiff, JC | 1 |
Hazen-Martin, DJ; Hutchison, FN; Morinelli, TA; Ullian, ME | 1 |
Bernard, S; Corriu, C; Schott, C; Stoclet, JC | 1 |
Howarth, SR; Vallance, P; Wilson, CA | 1 |
al-Tubuly, R; Nunez, DJ; Owji, AA; Sebkhi, A; Wilkins, MR; Zhao, L | 1 |
Champion, HC; Kadowitz, PJ | 1 |
Craven, PA; DeRubertis, FR; Studer, RK | 1 |
Combes, X; Gourlain, H; Hervé, P; Mazmanian, M | 1 |
Carmines, PK; Didion, SP; Ikenaga, H; Mayhan, WG | 1 |
Bouskela, E; Lavielle, G; Vallez, MO; Verbeuren, TJ | 1 |
Mayhan, WG | 2 |
Brosnihan, KB; Ferrario, CM; Li, P | 1 |
Kendall, DA; Roberts, RE; Tomlinson, AE; Wilson, VG | 1 |
Hart-Favaloro, JL; Woodman, OL | 1 |
Brennecke, SP; Gude, NM; King, RG | 1 |
Au-Fliegner, M; Gosche, JR; Salami, S | 1 |
Frank, DU; Horstman, DJ; Rich, GF | 1 |
Bivalacqua, TJ; Champion, HC; Kadowitz, PJ; Lambert, DG; McNamara, DB | 1 |
Ahluwalia, A; Scotland, R; Vallance, P | 1 |
Bivalacqua, TJ; Champion, HC; D'Souza, FM; Heistad, DD; Hyman, AL; Jeter, JR; Kadowitz, PJ; Ortiz, LA; Toyoda, K | 1 |
Bauer, J; Cavarape, A; Dau, C; Ehmke, H; Parekh, N; Schaefer, F | 1 |
Cruz, BV; Escalante, B | 1 |
He, GW; Yang, CQ | 1 |
Grobuschek, T; Hammer-Kogler, S; Juan, H; Sametz, W; Wintersteiger, R | 1 |
Bessard, G; Chavanon, O; Devillier, P; Sessa, C; Stanke-Labesque, F; Tripodi, F | 1 |
Bessard, G; Chavanon, O; Cracowski, JL; Devillier, P; Hunt, M; Sessa, C; Stanke-Labesque, F | 1 |
Cocks, TM; Jiang, GC; Moffatt, JD; Tatoulis, J | 1 |
Brockman, D; Eis, A; Kossenjans, W; Myatt, L; Sahay, R | 1 |
Casado, S; Castilla, C; Farré, J; Gómez, J; Guerra, JI; Jiménez, AM; López-Farré, A; Marcos, P; Montón, M; Núñez, A; Rico, L; Rodríguez-Feo, JA; Sánchez De Miguel, L | 1 |
Casado, S; Farré, J; Gómez, J; Jiménez, A; López-Blaya, A; López-Farré, A; Montón, M; Núñez, A; Sánchez de Miguel, L; Zalba, LR | 1 |
Asghar, AU; Bountra, C; Coleman, RA; McQueen, DS; Wheeldon, A | 1 |
Arif, AS; Banister, RE; Bivalacqua, TJ; D'Souza, FM; De Witt, BJ; Ibrahim, IN; Kaye, AD; Nossaman, BD | 1 |
Jeffery, TK; Wanstall, JC | 1 |
Bautista, R; Escalante, B; Hernández, J; Oyekan, A; Sánchez, A | 1 |
Newaz, MA; Oyekan, AO | 1 |
Heller, J; Malago, M; Molderings, GJ; Neef, M; Paschke, S; Sauerbruch, T; Schepke, M; Spengler, U; Thomas, J; Wolff, M | 1 |
Kitiyakara, C; Verbalis, JG; Welch, WJ; Wilcox, CS | 1 |
Benzoni, D; Liu, KL; Oréa, V | 1 |
Bivalacqua, TJ; Champion, HC; De Witt, BJ; Inscho, EW; Kadowitz, PJ; Shah, MK | 1 |
Hilbun, LR; Pallone, TL; Silldorff, EP | 1 |
Chang, TH; Wang, HL; Zhang, XH | 1 |
Ajayi, AA; Cory, J; Hayes, BE; Hercule, H; Oyekan, AO | 1 |
Hartshorne, DJ; Isaka, N; Ito, M; Kureishi, Y; Moriki, N; Nakano, T; Okamoto, R; Onishi, K; Seko, T | 1 |
Bauer, J; Parekh, N | 1 |
Bessard, G; Caron, F; Cracowski, JL; Hakim, A; Hoffmann, P; Sessa, C; Stanke-Labesque, F | 1 |
Baber, SR; Hyman, AL; Kadowitz, PJ | 1 |
Danser, AH; de Vries, R; Saxena, PR; Schuijt, MP; Sluiter, W; Tom, B; van Kats, JP | 1 |
Lao, TT; Leung, SW; Man, RY; Quan, A | 1 |
Didion, SP; Faraci, FM; Mathur, S; Ryan, MJ; Sigmund, CD | 1 |
Chabrashvili, T; Wang, D; Wilcox, CS | 1 |
Baber, SR; Fields, AM; Hoover, JM; Ibrahim, IN; Kaye, AD | 1 |
Deng, P; Epstein, DL; Rao, PV; Sasaki, Y | 1 |
Campbell, WB; Edwards, EM; Gauthier, KM; Holmes, B; Zhang, DX | 1 |
Campbell, DJ; Chirkov, YY; Horowitz, JD; Rajendran, S | 1 |
Gong, MC; Guo, Z; Pang, H; Su, W; Xie, Z | 1 |
Newaz, M; Oyekan, A; Yousefipour, Z | 2 |
Deering, SH; Gotkin, JL; Hoeldtke, NJ; Howard, BC; Napolitano, PG; Paonessa, DJ; Shields, AD | 1 |
Black, MJ; Boon, WM; Bubb, KJ; Cock, ML; Dodic, M; Harding, R; Parkington, HC; Tare, M | 1 |
Honma, S; Kurimoto, T; Nakahata, N; Ohkubo, S; Sato, Y; Shimura, T; Tanaka, T; Yoshida, M | 1 |
Arbeille, B; Bronquard, C; Cosnay, P; Fetissof, F; Findlay, I; Freslon, JL; Maupoil, V | 1 |
Dick, GM; Harrison-Bernard, LM; Swafford, AN | 1 |
Hercule, H; Newaz, M; Oyekan, A; Truong, L; Yousefipour, Z | 1 |
Chen, Y; Luo, Z; Pearlman, A; Wilcox, CS | 1 |
Campbell, WB; Cui, L; Gauthier, KM; Nithipatikom, K; Zhang, DX | 1 |
Badejo, AM; Casey, DB; Dhaliwal, JS; Gallen, TB; Greco, AJ; Kadowitz, PJ | 1 |
Banhidy, F; Bekesi, G; Matrai, M; Mericli, M; Monos, E; Nadasy, GL; Szekacs, B; Szekeres, M; Várbíró, S | 1 |
Moore, LG; Pulgar, VM; Rose, JC; Yamashiro, H | 1 |
Conhaim, RL; Dovi, WF; Watson, KE | 1 |
Faraci, FM; Johnson, AW; Kinzenbaw, DA; Modrick, ML | 1 |
Calderon, LE; Gong, MC; Guo, Z; Liu, S; Su, W; Xie, Z | 1 |
Abushufa, AM; Eldehni, MT; Evans, PD; McIntyre, CW; O'Sullivan, SE; Odudu, A | 1 |
Kuda, Y; Kurata, Y; Shibamoto, T; Shinomiya, S; Tanida, M; Toga, H; Wang, M; Yamamoto, Y | 1 |
Kuda, Y; Kurata, Y; Shibamoto, T; Tanida, M; Wang, M | 1 |
El-Din, MM; El-Mas, MM; Elmallah, AI; Khedr, MM; Nasser, SA; Sabra, R | 1 |
1 review(s) available for angiotensin ii and 15-hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic acid
Article | Year |
---|---|
Amplifying interactions between spasmogens in vascular smooth muscle.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Angiotensin II; Animals; Colforsin; Cyclic AMP; Femoral Artery; Muscle, Smooth, Vascular; Prostaglandin Endoperoxides, Synthetic; Rabbits; Receptors, Angiotensin; Receptors, Serotonin; Receptors, Thromboxane; Second Messenger Systems; Serotonin; Thromboxane A2; Vasoconstrictor Agents | 1993 |
1 trial(s) available for angiotensin ii and 15-hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic acid
Article | Year |
---|---|
Role of thromboxane A2 in the vasoconstrictor response to endothelin-1, angiotensin II and 5-hydroxytryptamine in human placental vessels.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Angiotensin II; Endothelins; Female; Humans; In Vitro Techniques; Perfusion; Placenta; Pregnancy; Prostaglandin Endoperoxides, Synthetic; Reference Values; Serotonin; Thromboxane A2; Thromboxane B2; Vasoconstrictor Agents | 1995 |
98 other study(ies) available for angiotensin ii and 15-hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic acid
Article | Year |
---|---|
Regional vascular responses to thromboxane A2 analogue and their blockade with vapiprost, a selective thromboxane receptor blocking drug, in anesthetized dogs.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Anesthesia; Angiotensin II; Animals; Biphenyl Compounds; Blood Pressure; Dogs; Female; Heptanoic Acids; Male; Norepinephrine; Prostaglandin Endoperoxides, Synthetic; Receptors, Prostaglandin; Regional Blood Flow; Vasoconstrictor Agents | 1992 |
Enhanced contraction to noradrenaline, serotonin and nerve stimulation but normal endothelium-derived relaxing factor response in skin small arteries in human primary hypertension.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Acetylcholine; Adult; Angiotensin II; Arteries; Data Interpretation, Statistical; Dose-Response Relationship, Drug; Electric Stimulation; Humans; Hypertension; Male; Middle Aged; Muscle, Smooth, Vascular; Myography; Nitric Oxide; Norepinephrine; Prostaglandin Endoperoxides, Synthetic; Serotonin; Skin; Vascular Resistance; Vasoconstriction; Vasoconstrictor Agents | 1992 |
Estradiol potentiates the vasopressor response of the isolated perfused rat lung to the thromboxane mimic U-46619.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Angiotensin II; Animals; Dose-Response Relationship, Drug; Drug Synergism; Estradiol; Female; Indomethacin; Lung; Male; Organ Size; Ovariectomy; Prostaglandin Endoperoxides, Synthetic; Rats; Rats, Inbred Strains; Sex Factors; Vasoconstrictor Agents | 1992 |
Study of tachyphylaxis to the vasoconstrictor effect of arachidonic acid in the isolated perfused kidney of the rat.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Angiotensin II; Animals; Arachidonic Acid; Arachidonic Acids; Endothelium, Vascular; Kidney; Male; Perfusion; Prostaglandin Endoperoxides, Synthetic; Prostaglandins; Rats; Rats, Inbred Strains; Tachyphylaxis; Thromboxane B2; Vasoconstriction | 1990 |
Exaggerated renal vascular reactivity to angiotensin and thromboxane in young genetically hypertensive rats.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Angiotensin II; Animals; Hypertension; Indomethacin; Kidney; Prostaglandin Endoperoxides, Synthetic; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Regression Analysis; Renal Circulation; Thromboxane A2; Time Factors; Vascular Resistance; Vasoconstriction; Vasodilation | 1990 |
Influence of nisoldipine on vascular resistance and vasoconstrictor responses in cats.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Angiotensin II; Animals; Azepines; Blood Pressure; Brimonidine Tartrate; Cardiac Output; Cats; Dinoprost; Dioxanes; Electric Stimulation; Female; Idazoxan; Male; Methoxamine; Nifedipine; Nisoldipine; Norepinephrine; Phenylephrine; Prostaglandin Endoperoxides, Synthetic; Prostaglandins F; Quinoxalines; Splanchnic Circulation; Sulfonamides; Sympathetic Nervous System; Tyramine; Vascular Resistance; Vasoconstriction | 1987 |
Methylene blue selectively inhibits pulmonary vasodilator responses in cats.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Acetylcholine; Angiotensin II; Animals; Blood Pressure; Bradykinin; Cats; Cyclic GMP; Epinephrine; Female; Isoproterenol; Male; Methylene Blue; Nitroglycerin; Prostaglandin Endoperoxides, Synthetic; Pulmonary Artery; Pulmonary Circulation; Reference Values; Vasodilation | 1989 |
Leukotrienes cause mesenteric vasoconstriction and hemoconcentration in rats without activating thromboxane receptors.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Acetophenones; Angiotensin II; Animals; Blood Pressure; Dicarboxylic Acids; Dinoprost; Hematocrit; Male; Mesenteric Arteries; Prostaglandin Endoperoxides, Synthetic; Rats; Rats, Inbred Strains; Receptors, Prostaglandin; Receptors, Thromboxane; SRS-A; Tetrazoles; Thromboxane A2; Vasoconstriction | 1989 |
Barbiturate anesthetics inhibit thromboxane-, potassium-, but not angiotensin-induced pulmonary vasoconstriction.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Angiotensin II; Animals; Barbiturates; Lung; Male; Pentobarbital; Peroxides; Potassium Chloride; Prostaglandin Endoperoxides, Synthetic; Rabbits; tert-Butylhydroperoxide; Thiopental; Thromboxanes; Vasoconstriction | 1989 |
Renal vascular reactivity to U 46619 and adrenergic agonists in Goldblatt hypertension.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Adrenergic beta-Agonists; Angiotensin II; Animals; Blood Pressure; Dogs; Female; Hypertension, Renovascular; Kidney; Male; Norepinephrine; Prostaglandin Endoperoxides, Synthetic; Regional Blood Flow; Renin; Vasoconstriction | 1987 |
Thromboxane agonist (U46619) potentiates norepinephrine efflux from adrenergic nerves.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Angiotensin II; Animals; Bridged Bicyclo Compounds, Heterocyclic; Dose-Response Relationship, Drug; Fatty Acids, Unsaturated; Hydrazines; In Vitro Techniques; Male; Muscle Contraction; Norepinephrine; Prostaglandin Endoperoxides, Synthetic; Rabbits; Receptors, Cell Surface; Receptors, Prostaglandin; Receptors, Thromboxane; Sympathetic Nervous System; Thromboxanes; Tritium; Vas Deferens | 1986 |
Role of pressor prostanoids in rats with angiotensin II-salt-induced hypertension.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Angiotensin II; Animals; Arteries; Bridged Bicyclo Compounds, Heterocyclic; Dinoprost; Fatty Acids, Unsaturated; Hydrazines; Hypertension; Imidazoles; Kidney Cortex; Male; Prostaglandin Endoperoxides; Prostaglandin Endoperoxides, Synthetic; Prostaglandins F; Rats; Rats, Inbred Strains; Sodium Chloride; Thromboxane A2; Thromboxane B2; Thromboxane-A Synthase | 1988 |
The actions of prostaglandins and their interactions with angiotensin II in the isolated perfused human placental cotyledon.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Alprostadil; Angiotensin II; Dinoprostone; Drug Interactions; Epoprostenol; Female; Humans; In Vitro Techniques; Perfusion; Placenta; Pregnancy; Prostaglandin D2; Prostaglandin Endoperoxides, Synthetic; Prostaglandins; Prostaglandins D; Prostaglandins E; Prostaglandins, Synthetic; Vasoconstriction | 1986 |
Differential calcium dependence of contractile responses and 86Rb efflux from the rabbit aorta induced by vasoactive stimuli.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Angiotensin II; Animals; Aorta, Abdominal; Calcium; Female; Histamine; Male; Muscle Contraction; Muscle, Smooth, Vascular; Norepinephrine; Potassium; Prostaglandin Endoperoxides, Synthetic; Rabbits; Rubidium | 1983 |
Prostacyclin and cerebral vessel relaxation.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Angiotensin II; Animals; Basilar Artery; Cerebrospinal Fluid; Dose-Response Relationship, Drug; Epoprostenol; Guinea Pigs; Ischemic Attack, Transient; Norepinephrine; Prostaglandin Endoperoxides, Synthetic; Prostaglandins; Prostaglandins F; Serotonin; Serotonin Antagonists; Thromboxane A2; Vasoconstriction | 1982 |
Vasoconstrictor responses after neo-intima formation and endothelial removal in the rabbit carotid artery.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Angiotensin I; Angiotensin II; Animals; Arginine; Carotid Arteries; Endothelium, Vascular; In Vitro Techniques; Male; Muscle Contraction; Muscle, Smooth, Vascular; Neovascularization, Pathologic; Nitric Oxide; Nitroarginine; omega-N-Methylarginine; Potassium Chloride; Prostaglandin Endoperoxides, Synthetic; Rabbits; Serotonin; Thromboxane A2; Vasoconstriction; Vasoconstrictor Agents | 1994 |
Bradykinin-induced in vitro contraction of rat mesangial cells via a B2 receptor type.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Adrenergic beta-2 Receptor Antagonists; Angiotensin II; Animals; Arginine Vasopressin; Bombesin; Bradykinin; Bridged Bicyclo Compounds; Bridged Bicyclo Compounds, Heterocyclic; Cell Membrane; Cells, Cultured; Dinoprost; Dinoprostone; Dose-Response Relationship, Drug; Endothelins; Fatty Acids, Unsaturated; Glomerular Mesangium; Indomethacin; Kinetics; Naphthalenes; Neomycin; Polycyclic Compounds; Prostaglandin Endoperoxides, Synthetic; Protein Kinase C; Quinacrine; Rats; Receptors, Adrenergic, beta-2; Surface Properties; Tetradecanoylphorbol Acetate; Thromboxane A2; Vasoconstrictor Agents | 1994 |
Influence of protein kinase C inhibitors on vasoconstrictor responses in the pulmonary vascular bed of cat and rat.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Alkaloids; Angiotensin II; Animals; Cats; Female; Lung; Male; Naphthalenes; Norepinephrine; Polycyclic Compounds; Prostaglandin Endoperoxides, Synthetic; Protein Kinase C; Rats; Rats, Sprague-Dawley; Serotonin; Staurosporine; Thromboxane A2; Vasoconstriction | 1995 |
Analysis of responses to angiotensin peptides in the hindquarters vascular bed of the cat.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Acetylcholine; Angiotensin I; Angiotensin II; Angiotensin III; Angiotensin Receptor Antagonists; Angiotensins; Animals; Arachidonic Acid; Arginine; Blood Flow Velocity; Captopril; Cats; Dose-Response Relationship, Drug; Female; Hindlimb; Imidazoles; Male; Meclofenamic Acid; Muscle, Skeletal; NG-Nitroarginine Methyl Ester; Nitric Acid; Phentolamine; Prostaglandin Endoperoxides, Synthetic; Pyridines; Regional Blood Flow; Tetrazoles; Thromboxane A2; Vasoconstrictor Agents | 1995 |
Nitric oxide generation and hypoxic vasoconstriction in buffer-perfused rabbit lungs.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Angiotensin II; Animals; Arginine; Female; Hypoxia; In Vitro Techniques; Lung; Male; Nitric Oxide; omega-N-Methylarginine; Perfusion; Prostaglandin Endoperoxides, Synthetic; Pulmonary Circulation; Rabbits; Thromboxane A2; Vasoconstriction | 1995 |
[Losartan prevents pulmonary hypertension induced by a thromboxane A2 analog].
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Angiotensin II; Animals; Antihypertensive Agents; Biphenyl Compounds; Hypertension, Pulmonary; Imidazoles; Losartan; Prostaglandin Endoperoxides, Synthetic; Rats; Rats, Sprague-Dawley; Tetrazoles; Thromboxane A2; Vasoconstrictor Agents | 1994 |
No evidence for a general change in contractile responsiveness of the mesenteric artery with aging.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Aging; Angiotensin II; Calcium; Dose-Response Relationship, Drug; Female; Humans; In Vitro Techniques; Male; Mesenteric Arteries; Norepinephrine; Prostaglandin Endoperoxides, Synthetic; Serotonin; Thromboxane A2; Vasoconstriction; Vasoconstrictor Agents | 1995 |
Prevention of thromboxane A2 receptor-mediated pulmonary hypertension by a nonpeptide angiotensin II type 1 receptor antagonist.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Biphenyl Compounds; Blood Pressure; Bridged Bicyclo Compounds, Heterocyclic; Enalapril; Fatty Acids, Unsaturated; Hematocrit; Hydrazines; Hypertension, Pulmonary; Imidazoles; Losartan; Male; Prostaglandin Endoperoxides, Synthetic; Rats; Rats, Sprague-Dawley; Receptors, Thromboxane; Tetrazoles; Thromboxane A2 | 1994 |
Renovascular actions of angiotensin II in the isolated kidney of the rat: relationship to lipoxygenases.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; 4,5-Dihydro-1-(3-(trifluoromethyl)phenyl)-1H-pyrazol-3-amine; Angiotensin II; Animals; Butylated Hydroxytoluene; Cyclooxygenase Inhibitors; Filtration; Flavanones; Flavonoids; Glomerular Filtration Rate; In Vitro Techniques; Indomethacin; Kidney; Lipoxygenase; Lipoxygenase Inhibitors; Male; Perfusion; Prostaglandin Endoperoxides, Synthetic; Prostaglandin-Endoperoxide Synthases; Rats; Rats, Sprague-Dawley; Sensitivity and Specificity; Vascular Resistance | 1993 |
Angiotensin II-aldosterone interactions on protein synthesis in vascular smooth muscle cells.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Aldosterone; Angiotensin II; Animals; Dexamethasone; Drug Interactions; Drug Synergism; Leucine; Male; Muscle Proteins; Muscle, Smooth, Vascular; Prostaglandin Endoperoxides, Synthetic; Rats; Rats, Sprague-Dawley; Receptors, Angiotensin; Up-Regulation | 1993 |
Effects of losartan on contractile responses of conductance and resistance arteries from rats.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Aorta; Biphenyl Compounds; Dinoprost; Imidazoles; In Vitro Techniques; Losartan; Male; Mesenteric Arteries; Prostaglandin Endoperoxides, Synthetic; Rats; Rats, Wistar; Tetrazoles; Thromboxane A2; Vasoconstriction | 1995 |
Angiotensin II receptor expression and inhibition in the chronically hypoxic rat lung.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Benzofurans; Hypertension, Pulmonary; Hypoxia; Lung; Male; Nitroprusside; Prostaglandin Endoperoxides, Synthetic; Rats; Rats, Wistar; Receptors, Angiotensin; Thromboxane A2 | 1996 |
Vasodilator responses to acetylcholine, bradykinin, and substance P are mediated by a TEA-sensitive mechanism.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Acetylcholine; Albuterol; Alprostadil; Analysis of Variance; Angiotensin II; Animals; Benzopyrans; Blood Pressure; Bradykinin; Cats; Cromakalim; Endothelium, Vascular; Female; Glyburide; Heart Rate; Hindlimb; Hydrazines; Isradipine; Male; Muscle, Smooth, Vascular; NG-Nitroarginine Methyl Ester; Nitrogen Oxides; Nitroprusside; Norepinephrine; Penicillamine; Prostaglandin Endoperoxides, Synthetic; Pyrroles; S-Nitroso-N-Acetylpenicillamine; Substance P; Tetraethylammonium; Tetraethylammonium Compounds; Thromboxane A2; Vasoactive Intestinal Peptide; Vasodilation; Vasodilator Agents | 1997 |
Antioxidant inhibition of protein kinase C-signaled increases in transforming growth factor-beta in mesangial cells.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Acetylcysteine; Angiotensin II; Animals; Antioxidants; Cells, Cultured; Enzyme Activation; Female; Glucose; Kidney Glomerulus; Phorbol 12,13-Dibutyrate; Prostaglandin Endoperoxides, Synthetic; Protein Kinase C; Rats; Rats, Sprague-Dawley; Taurine; Thromboxane A2; Thromboxanes; Transforming Growth Factor beta; Vitamin E | 1997 |
Effect of 48 hours of nitric oxide inhalation on pulmonary vasoreactivity in rats.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Administration, Inhalation; Angiotensin II; Animals; Arginine Vasopressin; In Vitro Techniques; Male; Muscle, Smooth, Vascular; Nitric Oxide; Nitroprusside; Prostaglandin Endoperoxides, Synthetic; Pulmonary Artery; Rats; Rats, Sprague-Dawley; Thromboxane A2; Time Factors; Vasoconstriction; Vasoconstrictor Agents; Vasodilation; Vasodilator Agents | 1997 |
Enhanced constrictor responses of skeletal muscle arterioles during chronic myocardial infarction.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Angiotensin II; Animals; Arginine Vasopressin; Arterioles; Coronary Vessels; Endothelin-1; Hemodynamics; Male; Muscle, Skeletal; Muscle, Smooth, Vascular; Myocardial Infarction; omega-N-Methylarginine; Prostaglandin Endoperoxides, Synthetic; Rats; Rats, Sprague-Dawley; Reference Values; Thromboxane A2; Time Factors; Vasoconstriction; Vasoconstrictor Agents | 1997 |
Activation of thromboxane receptors and the induction of vasomotion in the hamster cheek pouch microcirculation.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Angiotensin II; Animals; Arterioles; Carbazoles; Cheek; Cricetinae; Dose-Response Relationship, Drug; Heptanoic Acids; In Vitro Techniques; Male; Mesocricetus; Microcirculation; Nitric Oxide Synthase; Nitroarginine; Phenylephrine; Receptors, Thromboxane; Sulfonamides; Vasoconstriction; Vasoconstrictor Agents | 1997 |
Constrictor responses of the rat basilar artery during diabetes mellitus.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Angiotensin II; Animals; Arginine Vasopressin; Basilar Artery; Blood Pressure; Cerebrovascular Disorders; Diabetes Mellitus, Experimental; Endothelin-1; Enzyme Inhibitors; Male; Muscle, Smooth, Vascular; Nitric Oxide Synthase; omega-N-Methylarginine; Rats; Thromboxanes; Vasoconstriction; Vasoconstrictor Agents | 1998 |
Losartan inhibits thromboxane A2-induced platelet aggregation and vascular constriction in spontaneously hypertensive rats.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Acetylcholine; Angiotensin II; Animals; Antihypertensive Agents; Aorta; Endothelins; Endothelium, Vascular; Imidazoles; Losartan; Male; Platelet Aggregation; Platelet Aggregation Inhibitors; Rats; Rats, Inbred SHR; Receptors, Prostaglandin; Receptors, Thromboxane A2, Prostaglandin H2; Tetrazoles; Thromboxane A2; Vasoconstriction; Vasoconstrictor Agents | 1998 |
Alpha2-adrenoceptor-mediated contractions of the porcine isolated ear artery: evidence for a cyclic AMP-dependent and a cyclic AMP-independent mechanism.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Adrenergic alpha-Agonists; Angiotensin II; Animals; Arteries; Brimonidine Tartrate; Colforsin; Cyclic AMP; Ear; In Vitro Techniques; Muscle Contraction; Muscle Relaxation; Nitroprusside; Quinoxalines; Receptors, Adrenergic, alpha-2; Swine | 1998 |
Rabbit polymorphonuclear leukocytes release a factor that causes constriction of the coronary vasculature.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Amlodipine; Angiotensin II; Animals; Biological Factors; Bradykinin; Coronary Circulation; Female; Heart; In Vitro Techniques; Male; Neutrophils; Nitroprusside; Perfusion; Rabbits; Superoxides; Trypsin; Vasoconstriction | 1998 |
Autacoid interactions in the regulation of blood flow in the human placenta.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Angiotensin II; Drug Interactions; Eicosanoids; Endothelin-1; Enzyme Inhibitors; Female; Fetus; Free Radical Scavengers; Humans; Nitric Oxide; Nitroarginine; Placenta; Placental Circulation; Pregnancy; Serotonin; Vasoconstriction; Vasoconstrictor Agents; Vasodilator Agents | 1998 |
Pulmonary arterioles from rats with congenital diaphragmatic hernias are hypoplastic but not hyperresponsive.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Analysis of Variance; Angiotensin II; Animals; Arterioles; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Fetus; Herbicides; Hernia, Diaphragmatic; Hernias, Diaphragmatic, Congenital; Phenyl Ethers; Phenylephrine; Pregnancy; Pulmonary Circulation; Rats; Rats, Sprague-Dawley; Serotonin; Vasoconstriction; Vasoconstrictor Agents | 1998 |
The effect of prolonged inhaled nitric oxide on pulmonary vasoconstriction in rats.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Administration, Inhalation; Angiotensin II; Animals; Hypoxia; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Pulmonary Circulation; Rats; Rats, Sprague-Dawley; Time Factors; Vasoconstriction; Vasoconstrictor Agents; Vasodilator Agents | 1998 |
The influence of candesartan and PD123319 on responses to angiotensin II in the hindquarters vascular bed of the rat.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Benzimidazoles; Biphenyl Compounds; Calcium Channel Agonists; Dose-Response Relationship, Drug; Female; Hemodynamics; Hindlimb; Imidazoles; Injections, Intravenous; Male; Norepinephrine; Pyridines; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Tetrazoles; Vasoconstrictor Agents | 1999 |
On the regulation of tone in vasa vasorum.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Angiotensin II; Animals; Aorta; Bradykinin; Calcitonin Gene-Related Peptide; Cattle; Dose-Response Relationship, Drug; Endothelin-1; In Vitro Techniques; Isoproterenol; Norepinephrine; Prostaglandin Endoperoxides, Synthetic; Substance P; Swine; Vasa Vasorum; Vasoconstrictor Agents; Vasodilator Agents | 1999 |
Gene transfer of endothelial nitric oxide synthase to the lung of the mouse in vivo. Effect on agonist-induced and flow-mediated vascular responses.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Adenoviridae; Angiotensin II; Animals; Antimetabolites, Antineoplastic; beta-Galactosidase; Bleomycin; Blood Flow Velocity; Blood Pressure; Bradykinin; Cyclic GMP; Endothelin-1; Gene Transfer Techniques; Genes, Reporter; Hypertension, Pulmonary; Hypoxia; Mice; Mice, Inbred Strains; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Norepinephrine; Phosphodiesterase Inhibitors; Pulmonary Alveoli; Pulmonary Artery; Pulmonary Circulation; Pulmonary Wedge Pressure; Purinones; Sympathomimetics; Vasoconstrictor Agents | 1999 |
Acute infusion of nicotine potentiates norepinephrine-induced vasoconstriction in the hamster cheek pouch.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Angiotensin II; Animals; Arginine Vasopressin; Arterioles; Cheek; Cricetinae; Dose-Response Relationship, Drug; Drug Synergism; Infusions, Intravenous; Male; Mouth Mucosa; Nicotine; Nicotinic Agonists; Norepinephrine; omega-N-Methylarginine; Vasoconstriction | 1999 |
ANG II- and TxA(2)-induced mesenteric vasoconstriction in rats is mediated by separate cell signaling pathways.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Angiotensin II; Animals; Calcium; Calcium Channel Blockers; Calcium Channels; Dose-Response Relationship, Drug; Female; Hemodynamics; Mesentery; Protein Kinase C; Rats; Rats, Wistar; Signal Transduction; Thromboxane A2; Vasoconstriction; Vasoconstrictor Agents | 1999 |
Renal vascular interaction of angiotensin II and prostaglandins in renovascular hypertension.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Anesthesia; Angiotensin II; Animals; Arachidonic Acid; Bridged Bicyclo Compounds, Heterocyclic; Dose-Response Relationship, Drug; Drug Interactions; Fatty Acids, Unsaturated; Hydrazines; Hypertension, Renovascular; Indomethacin; Kidney; Perfusion; Prostaglandins; Rats; Vasoconstrictor Agents | 1999 |
Inhibition of vasoconstriction by the thromboxane A2 antagonist GR32191B in the human radial artery.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Angiotensin II; Biphenyl Compounds; Coronary Artery Bypass; Dinoprost; Heptanoic Acids; Humans; In Vitro Techniques; Muscle, Smooth, Vascular; Norepinephrine; Potassium; Prostaglandin Antagonists; Radial Artery; Thromboxane A2; Vasoconstrictor Agents | 1999 |
Influence of isoprostanes on vasoconstrictor effects of noradrenaline and angiotensin II.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Angiotensin II; Animals; Bridged Bicyclo Compounds, Heterocyclic; Dinoprost; Dose-Response Relationship, Drug; Drug Interactions; Ear; F2-Isoprostanes; Fatty Acids, Unsaturated; Female; Hydrazines; Male; Norepinephrine; Perfusion; Prostaglandins; Rabbits; Regional Blood Flow; Vasoconstriction; Vasoconstrictor Agents | 1999 |
Antagonistic effects of losartan on thromboxane A2-receptors in human isolated gastroepiploic artery and saphenous vein.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Angiotensin II; Angiotensin Receptor Antagonists; Antihypertensive Agents; Cyclooxygenase Inhibitors; Dose-Response Relationship, Drug; Endothelin-1; Humans; In Vitro Techniques; Indomethacin; Losartan; Muscle Contraction; Muscle, Smooth, Vascular; Nitroarginine; Norepinephrine; Potassium Chloride; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Prostaglandin; Receptors, Thromboxane; Receptors, Thromboxane A2, Prostaglandin H2; Saphenous Vein; Serotonin; Stomach | 1999 |
Functional comparison of the human isolated femoral artery, internal mammary artery, gastroepiploic artery, and saphenous vein.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Angiotensin II; Arteries; Dose-Response Relationship, Drug; Endothelin-1; Femoral Artery; Humans; In Vitro Techniques; Leukotriene C4; Mammary Arteries; Norepinephrine; Potassium Chloride; Saphenous Vein; Sensitivity and Specificity; Stomach; Vasoconstriction; Vasoconstrictor Agents | 1999 |
Storage of radial artery grafts in blood increases vessel reactivity to vasoconstrictors in vitro.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Acetylcholine; Angiotensin II; Blood; Endothelium, Vascular; Humans; In Vitro Techniques; Norepinephrine; Organ Preservation Solutions; Papaverine; Potassium Chloride; Radial Artery; Serotonin; Vasoconstriction; Vasoconstrictor Agents; Vasodilation | 1999 |
Role of peroxynitrite in altered fetal-placental vascular reactivity in diabetes or preeclampsia.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Adult; Angiotensin II; Antihypertensive Agents; Diabetes Mellitus, Type 1; Epoprostenol; Female; Fetus; Humans; In Vitro Techniques; Muscle, Smooth, Vascular; Nitrates; Nitric Oxide; Nitroglycerin; Oxidative Stress; Placenta; Pre-Eclampsia; Pregnancy; Reactive Oxygen Species; Tyrosine; Vasoconstriction; Vasoconstrictor Agents; Vasodilator Agents | 2000 |
[Effect of losartan on human platelet activation by thromboxane A2].
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Adult; Angiotensin II; Humans; Imidazoles; Losartan; Male; Platelet Activation; Receptors, Thromboxane; Tetrazoles; Thromboxane A2 | 2000 |
Comparative effects of angiotensin II AT-1-type receptor antagonists in vitro on human platelet activation.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Adenosine Diphosphate; Adult; Angiotensin II; Angiotensin Receptor Antagonists; Antibodies, Monoclonal; Benzimidazoles; Benzoates; Binding, Competitive; Biphenyl Compounds; Blood Platelets; Dose-Response Relationship, Drug; Humans; Imidazoles; Irbesartan; Losartan; Platelet Activation; Pyridines; Radioligand Assay; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Telmisartan; Tetrazoles; Thromboxane A2; Time Factors; Valine; Valsartan | 2000 |
Hoe 140 and pseudo-irreversible antagonism in the rat vas deferens in vitro.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Angiotensin II; Animals; Bradykinin; Bradykinin Receptor Antagonists; Dose-Response Relationship, Drug; Electric Stimulation; In Vitro Techniques; Male; Muscle Contraction; Muscle, Smooth; Norepinephrine; Rats; Rats, Wistar; Vas Deferens | 2000 |
Effects of PKC isozyme inhibitors on constrictor responses in the feline pulmonary vascular bed.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Acetophenones; Angiotensin II; Animals; Benzopyrans; Calcium Channel Agonists; Carbazoles; Cats; Drug Interactions; Enzyme Inhibitors; Female; Free Radical Scavengers; Immunohistochemistry; Indoles; Isoenzymes; Male; Muscle, Smooth, Vascular; Norepinephrine; Protein Kinase C; Protein Kinase C beta; Protein Kinase C-alpha; Pulmonary Circulation; Serotonin; Vasoconstriction; Vasoconstrictor Agents | 2001 |
Comparison of pulmonary vascular function and structure in early and established hypoxic pulmonary hypertension in rats.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Acetylcholine; Angiotensin I; Angiotensin II; Animals; Hemodynamics; Hypertension, Pulmonary; Hypoxia; In Vitro Techniques; Lung; Organ Size; Pulmonary Artery; Pulmonary Circulation; Rats; Rats, Wistar; Renin-Angiotensin System; Serotonin; Vasodilator Agents | 2001 |
Angiotensin II type AT(2) receptor mRNA expression and renal vasodilatation are increased in renal failure.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; 5,8,11,14-Eicosatetraynoic Acid; Angiotensin II; Animals; Antihypertensive Agents; Arachidonic Acid; Clotrimazole; Cytochrome P-450 Enzyme System; Dose-Response Relationship, Drug; Gene Expression Regulation; Imidazoles; In Vitro Techniques; Indomethacin; Kidney; Losartan; Male; NG-Nitroarginine Methyl Ester; Oligopeptides; Pyridines; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Renal Insufficiency; RNA, Messenger; Vasodilation | 2001 |
Vascular responses to endothelin-1, angiotensin-II, and U46619 in glycerol-induced acute renal failure.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Acute Kidney Injury; Angiotensin II; Animals; Disease Models, Animal; Dose-Response Relationship, Drug; Endothelin-1; Glycerol; In Vitro Techniques; Male; Perfusion; Rats; Rats, Sprague-Dawley; Vasoconstriction; Vasoconstrictor Agents | 2001 |
Contractile hyporesponsiveness of hepatic arteries in humans with cirrhosis: evidence for a receptor-specific mechanism.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Adult; Angiotensin II; Female; GTP-Binding Proteins; Hepatic Artery; Humans; In Vitro Techniques; Liver Cirrhosis; Male; Middle Aged; Receptors, Cell Surface; Sodium Fluoride; Tissue Donors; Vasoconstriction; Vasoconstrictor Agents | 2001 |
Role of thromboxane receptors in the dipsogenic response to central angiotensin II.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Angiotensin II; Animals; Brain; Drinking; Drug Interactions; Injections, Intravenous; Injections, Intraventricular; Male; Rats; Rats, Sprague-Dawley; Receptors, Thromboxane; Saline Solution, Hypertonic | 2002 |
Vascular reactivity to angiotensin II alone or combined with a thromboxane A2 mimetic in the isolated perfused kidney of Lyon hypertensive rats.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Angiotensin II; Animals; Dose-Response Relationship, Drug; Drug Synergism; Genetic Predisposition to Disease; Hypertension; In Vitro Techniques; Kidney; Male; Perfusion; Rats; Rats, Inbred Strains; Receptors, Prostaglandin; Receptors, Thromboxane; Receptors, Thromboxane A2, Prostaglandin H2; Vascular Resistance; Vasoconstrictor Agents; Vasomotor System | 2002 |
Comparative responses to alpha,beta-methylene-ATP in cat pulmonary, mesenteric, and hindquarter vascular beds.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Adenosine Triphosphate; Angiotensin II; Animals; Blood Vessels; Cats; Dose-Response Relationship, Drug; Female; Hindlimb; Male; Mesenteric Arteries; Perfusion; Pressure; Prostaglandin-Endoperoxide Synthases; Pulmonary Circulation; Purinergic P2 Receptor Antagonists; Pyridoxal Phosphate; Receptor, Angiotensin, Type 1; Receptors, Adrenergic, alpha; Receptors, Angiotensin; Vasoconstrictor Agents | 2002 |
Angiotensin II constriction of rat vasa recta is partially thromboxane dependent.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; 5,8,11,14-Eicosatetraynoic Acid; Angiotensin II; Animals; Benzofurans; Blood Vessels; Bridged Bicyclo Compounds, Heterocyclic; Culture Techniques; Cyclooxygenase Inhibitors; Enzyme Inhibitors; Fatty Acids, Unsaturated; Female; Hydrazines; Indomethacin; Kidney Medulla; Kinetics; Lipoxygenase Inhibitors; Potassium Chloride; Rats; Rats, Sprague-Dawley; Receptors, Thromboxane; Thromboxane-A Synthase; Thromboxanes; Vasoconstriction; Vasoconstrictor Agents | 2002 |
Effects of tetrandrine on smooth muscle contraction induced by mediators in pulmonary hypertension.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Alkaloids; Angiotensin II; Animals; Antihypertensive Agents; Benzylisoquinolines; Endothelin-1; Guinea Pigs; Hypertension, Pulmonary; Male; Muscle Contraction; Muscle, Smooth, Vascular; Neuropeptide Y; Pulmonary Artery; Rats; Rats, Sprague-Dawley; SRS-A | 2002 |
Gender difference in vascular and platelet reactivity to thromboxane A(2)-mimetic U46619 and to endothelial dependent vasodilation in Zucker fatty (hypertensive, hyperinsulinemic) diabetic rats.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Angiotensin II; Animals; Blood Pressure; Diabetes Mellitus, Type 2; Endothelin-1; Endothelium, Vascular; Enzyme Inhibitors; Female; Kidney Cortex; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Phenylephrine; Platelet Aggregation; Rats; Rats, Zucker; Renal Circulation; Sex Characteristics; Vasoconstrictor Agents; Vasodilation | 2003 |
Activation of RhoA and inhibition of myosin phosphatase as important components in hypertension in vascular smooth muscle.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Amides; Angiotensin II; Animals; Cells, Cultured; Cyclic GMP; Endothelin-1; Enzyme Activation; Enzyme Inhibitors; Hypertension; Indoles; Intracellular Signaling Peptides and Proteins; Maleimides; Muscle Proteins; Muscle, Smooth, Vascular; Myosin-Light-Chain Phosphatase; NG-Nitroarginine Methyl Ester; Phosphoprotein Phosphatases; Phosphoproteins; Phosphorylation; Protein Kinase C; Protein Serine-Threonine Kinases; Pyridines; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Rats, Sprague-Dawley; rho-Associated Kinases; rhoA GTP-Binding Protein; Signal Transduction; Threonine | 2003 |
Variations in cell signaling pathways for different vasoconstrictor agonists in renal circulation of the rat.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Amides; Angiotensin II; Animals; Arginine Vasopressin; Blood Pressure; Calcium Channel Blockers; Enzyme Inhibitors; Female; Gallic Acid; Indoles; Nifedipine; Norepinephrine; Pyridines; Rats; Rats, Wistar; Renal Circulation; Signal Transduction; Staurosporine; Vasoconstrictor Agents | 2003 |
Functional comparison of the antagonistic properties of some Angiotensin II type 1 receptor blockers on the contraction elicited by Angiotensin II and thromboxane A2 on human saphenous veins.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Biphenyl Compounds; Drug Antagonism; Humans; Imidazoles; In Vitro Techniques; Irbesartan; Losartan; Muscle Contraction; Muscle, Smooth, Vascular; Receptors, Thromboxane A2, Prostaglandin H2; Saphenous Vein; Tetrazoles; Valine; Valsartan | 2003 |
Role of COX-1 and -2 in prostanoid generation and modulation of angiotensin II responses.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Alprostadil; Angiotensin II; Animals; Arachidonic Acid; Blood Pressure; Cardiac Catheterization; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Isoenzymes; Membrane Proteins; Nitrobenzenes; Platelet Aggregation; Prostaglandin-Endoperoxide Synthases; Prostaglandins; Pulmonary Circulation; Pyrazoles; Rats; Rats, Sprague-Dawley; Sulfonamides; Vasoconstrictor Agents; Vasodilator Agents | 2003 |
Superoxide does not mediate the acute vasoconstrictor effects of angiotensin II: a study in human and porcine arteries.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Acetophenones; Adolescent; Adult; Angiotensin II; Animals; Catecholamines; Child; Child, Preschool; Coronary Vessels; Cyclic N-Oxides; Dopamine Agonists; Dose-Response Relationship, Drug; Endothelin-1; Enzyme Inhibitors; Female; Femoral Artery; Free Radical Scavengers; Humans; Imidazolines; Male; Myocardial Contraction; NAD; NADP; Nitroprusside; Oxidants; S-Nitroso-N-Acetylpenicillamine; Spin Labels; Superoxide Dismutase; Superoxides; Swine; Time Factors; Vasoconstriction; Vasoconstrictor Agents; Vasodilation; Vasodilator Agents; Xanthine Oxidase | 2003 |
5-hydroxytryptamine and thromboxane A2 as physiologic mediators of human umbilical artery closure.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Acetylcholine; Angiotensin II; Bradykinin; Endothelin-1; Female; Histamine; Humans; In Vitro Techniques; Muscle Contraction; Muscle, Smooth, Vascular; Norepinephrine; Oxygen; Phenylephrine; Pregnancy; Serotonin; Thromboxane A2; Umbilical Arteries; Vasoconstriction; Vasoconstrictor Agents | 2003 |
Angiotensin II-induced vascular dysfunction is mediated by the AT1A receptor in mice.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Acetylcholine; Amides; Angiotensin II; Animals; Aorta; Carotid Arteries; Infusion Pumps, Implantable; Mice; Mice, Inbred C57BL; Mice, Knockout; Nitric Oxide; Nitroprusside; Papaverine; Phenylephrine; Potassium Chloride; Pyridines; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Reverse Transcriptase Polymerase Chain Reaction; rhoA GTP-Binding Protein; Sequence Deletion; Serotonin; Superoxides; Vasoconstriction; Vasoconstrictor Agents; Vasodilator Agents | 2004 |
Enhanced contractility of renal afferent arterioles from angiotensin-infused rabbits: roles of oxidative stress, thromboxane prostanoid receptors, and endothelium.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; 8,11,14-Eicosatrienoic Acid; Angiotensin II; Animals; Arterioles; Bridged Bicyclo Compounds, Heterocyclic; Cyclic N-Oxides; Cyclooxygenase 2; Dose-Response Relationship, Drug; Endothelin-1; Endothelins; Endothelium, Vascular; Isoenzymes; Kidney; Male; Nitroarginine; Norepinephrine; Oxazoles; Oxidative Stress; Prostaglandin-Endoperoxide Synthases; Pyrazoles; Rabbits; Receptors, Thromboxane; RNA, Messenger; Spin Labels; Superoxides; Vascular Resistance; Vasoconstriction | 2004 |
Effects of norepinephrine on alpha-subtype receptors in the feline pulmonary vascular bed.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Angiotensin II; Animals; Cats; Clonidine; Dose-Response Relationship, Drug; Drug Antagonism; Drug Evaluation, Preclinical; Ephedrine; Female; Injections, Intra-Arterial; Injections, Intravenous; Male; Norepinephrine; Phenylephrine; Piperazines; Pulmonary Artery; Pulmonary Circulation; Receptors, Adrenergic, alpha-1; Vascular Resistance; Vasoconstrictor Agents | 2004 |
Regulation of myosin light chain phosphorylation in the trabecular meshwork: role in aqueous humour outflow facility.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Angiotensin II; Aqueous Humor; Cells, Cultured; Endothelin-1; Enzyme Inhibitors; GTP-Binding Protein alpha Subunits, G12-G13; Humans; Intracellular Signaling Peptides and Proteins; Muscle Proteins; Myosin Light Chains; Phosphoprotein Phosphatases; Phosphoproteins; Phosphorylation; Protein Serine-Threonine Kinases; Reverse Transcriptase Polymerase Chain Reaction; rho GTP-Binding Proteins; rho-Associated Kinases; Trabecular Meshwork | 2005 |
Angiotensin II dilates bovine adrenal cortical arterioles: role of endothelial nitric oxide.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Adrenal Cortex; Angiotensin II; Animals; Arterioles; Cattle; Endothelium, Vascular; Losartan; Nitric Oxide; Nitric Oxide Donors; Nitroso Compounds; Vasoconstriction; Vasoconstrictor Agents; Vasodilator Agents | 2005 |
Angiotensin-(1-7) enhances anti-aggregatory effects of the nitric oxide donor sodium nitroprusside.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Adult; Aged; Angiotensin I; Angiotensin II; Antihypertensive Agents; Coronary Disease; Drug Synergism; Female; Humans; Male; Myocardial Infarction; Nitric Oxide Donors; Nitroprusside; Peptide Fragments; Platelet Aggregation; Platelet Aggregation Inhibitors; Vasoconstrictor Agents | 2005 |
Divergent kinase signaling mediates agonist-induced phosphorylation of phosphatase inhibitory proteins PHI-1 and CPI-17 in vascular smooth muscle cells.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Angiotensin II; Animals; Muscle Proteins; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Phosphoproteins; Phosphorylation; Protein Serine-Threonine Kinases; Proteins; Rats; Rats, Sprague-Dawley; Signal Transduction; Thrombin | 2006 |
Role of PPAR-gamma on the pathogenesis and vascular changes in glycerol-induced acute renal failure.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Acute Kidney Injury; Angiotensin II; Animals; Ascorbic Acid; Clofibrate; Down-Regulation; Free Radicals; Glycerol; Kidney; Male; Nitric Oxide; Nitriles; PPAR gamma; Rats; Rats, Sprague-Dawley; Renal Circulation; Thiazolidinediones; Thromboxane A2; Vasoconstriction | 2006 |
17-Hydroxyprogesterone caproate reverses induced vasoconstriction of the fetoplacental arteries by the thromboxane mimetic U46619.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; 17 alpha-Hydroxyprogesterone Caproate; Angiotensin II; Cytokines; Female; Fetus; Humans; Hydroxyprogesterones; Placenta; Pregnancy; Vasoconstriction | 2006 |
Intrauterine growth restriction delays cardiomyocyte maturation and alters coronary artery function in the fetal sheep.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Angiotensin II; Animals; Bradykinin; Cell Differentiation; Coronary Vessels; Endothelium, Vascular; Female; Fetal Growth Retardation; Heart; Muscle, Smooth, Vascular; Myocytes, Cardiac; Pregnancy; Sheep; Vasoconstrictor Agents; Vasodilator Agents | 2007 |
Distinct effects of z-335, a new thromboxane A2 receptor antagonist, on rabbit platelets and aortic smooth muscle.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Angiotensin II; Animals; Aorta, Thoracic; Blood Platelets; Bridged Bicyclo Compounds, Heterocyclic; Cell Shape; Cells, Cultured; Dose-Response Relationship, Drug; Endothelins; Fatty Acids, Unsaturated; Hydrazines; In Vitro Techniques; Indans; Inositol Phosphates; Male; Muscle, Smooth, Vascular; Norepinephrine; Platelet Aggregation; Rabbits; Radioligand Assay; Receptors, Thromboxane A2, Prostaglandin H2; Tritium; Vasoconstriction; Vasoconstrictor Agents | 2007 |
Contractile and relaxant properties of rat-isolated pulmonary veins related to localization and histology.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Acetylcholine; Adrenergic beta-2 Receptor Agonists; Adrenergic beta-2 Receptor Antagonists; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Albuterol; Angiotensin II; Animals; Bradykinin; Bronchi; Endothelium, Vascular; Heart Atria; In Vitro Techniques; Isoproterenol; Male; Nitroprusside; Phenylephrine; Propanolamines; Pulmonary Veins; Rats; Rats, Wistar; Receptors, Adrenergic, beta-2; Vasoconstriction; Vasoconstrictor Agents; Vasodilation; Vasodilator Agents | 2007 |
Knockout mice reveal that the angiotensin II type 1B receptor links to smooth muscle contraction.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Angiotensin II; Animals; Aorta, Abdominal; In Vitro Techniques; Isometric Contraction; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Muscle, Smooth, Vascular; Myography; Potassium Chloride; Receptor, Angiotensin, Type 1; Vasoconstriction; Vasoconstrictor Agents | 2007 |
Ciglitazone, a peroxisome proliferator-activated receptor gamma inducer, ameliorates renal preglomerular production and activity of angiotensin II and thromboxane A2 in glycerol-induced acute renal failure.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Acute Kidney Injury; Angiotensin II; Animals; Creatinine; Dinoprost; Gene Expression; Glycerol; Hypoglycemic Agents; Kidney Glomerulus; Male; Nitric Oxide; Nitrites; PPAR gamma; Proteinuria; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptors, Thromboxane A2, Prostaglandin H2; Renal Artery; Sodium; Thiazolidinediones; Thromboxane A2; Thromboxane B2; Vasoconstriction | 2007 |
Hydrogen peroxide mediates a transient vasorelaxation with tempol during oxidative stress.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Angiotensin II; Animals; Antioxidants; Catalase; Cells, Cultured; Cyclic N-Oxides; Dose-Response Relationship, Drug; Endothelium, Vascular; Hydrogen Peroxide; In Vitro Techniques; Male; Mesenteric Arteries; Mice; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Nitroblue Tetrazolium; Norepinephrine; Oxidative Stress; Potassium Channels; Rats; Rats, Inbred SHR; Spin Labels; Superoxide Dismutase; Superoxides; Vasoconstrictor Agents; Vasodilation; Vasodilator Agents | 2007 |
Angiotensin II relaxations of bovine adrenal cortical arteries: role of angiotensin II metabolites and endothelial nitric oxide.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Adrenal Cortex; Angiotensin I; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin II Type 2 Receptor Blockers; Angiotensin III; Animals; Arteries; Cattle; Endothelium, Vascular; Imidazoles; Losartan; Nitric Oxide; Peptide Fragments; Pyridines; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Vasoconstriction; Vasoconstrictor Agents; Vasodilation | 2008 |
Analysis of pulmonary vasodilator responses to the Rho-kinase inhibitor fasudil in the anesthetized rat.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Anesthesia; Angiotensin II; Animals; Blood Gas Analysis; Blood Pressure; Cardiac Output; Heart Rate; Hypoxia; Injections, Intravenous; Isradipine; Lung; Male; NG-Nitroarginine Methyl Ester; Protein Kinase Inhibitors; Pulmonary Circulation; Rats; Rats, Sprague-Dawley; rho-Associated Kinases; Vascular Resistance; Vasodilator Agents | 2008 |
Biomechanics and vasoreactivity of female intramural coronaries in angiotensin II induced hypertension.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Angiotensin II; Animals; Biomechanical Phenomena; Capillary Resistance; Coronary Vessels; Female; Hypertension; Models, Biological; Rats; Rats, Sprague-Dawley; Receptors, Thromboxane A2, Prostaglandin H2; Vasoconstriction; Vasoconstrictor Agents | 2010 |
Natriuretic and renoprotective effect of chronic oral neutral endopeptidase inhibition in acute renal failure.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Acute Kidney Injury; Administration, Oral; Angiotensin II; Animals; Antihypertensive Agents; Creatinine; Endothelin-1; Indans; Kidney; Male; Natriuresis; Neprilysin; Nitrates; Propionates; Proteinuria; Rats; Rats, Sprague-Dawley; Thromboxane A2; Vasoconstriction; Vasoconstrictor Agents | 2010 |
Role of the AT2 receptor in modulating the angiotensin II contractile response of the uterine artery at mid-gestation.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Acetylcholine; Angiotensin II; Animals; Blood Pressure; Female; Heart Rate; Humans; In Vitro Techniques; Male; Mice; Mice, Inbred C57BL; Potassium Chloride; Pregnancy; Receptor, Angiotensin, Type 2; Uterine Artery; Vasoconstriction; Vasodilation | 2011 |
Evidence for active control of perfusion within lung microvessels.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Angiotensin II; Animals; Bradykinin; In Vitro Techniques; Lung; Male; Microvessels; Perfusion; Rats; Rats, Sprague-Dawley; Serotonin; Vasoconstriction; Vasoconstrictor Agents | 2012 |
Small-molecule inhibitors of signal transducer and activator of transcription 3 protect against angiotensin II-induced vascular dysfunction and hypertension.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Aminosalicylic Acids; Angiotensin II; Animals; Antihypertensive Agents; Aorta; Benzenesulfonates; Carotid Arteries; Cyclic S-Oxides; Endothelium, Vascular; Hypertension; Male; Mice; Nitroprusside; Oxidative Stress; Phosphorylation; STAT3 Transcription Factor; Superoxides; Vasoconstrictor Agents; Vasodilator Agents | 2013 |
Smooth muscle-selective CPI-17 expression increases vascular smooth muscle contraction and blood pressure.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Angiotensin II; Animals; Blood Pressure; Calcium; Intracellular Signaling Peptides and Proteins; Isometric Contraction; Mesenteric Arteries; Mice; Mice, Inbred C57BL; Mice, Transgenic; Muscle Proteins; Muscle, Smooth, Vascular; Phenylephrine; Phosphoproteins; Potassium; Serotonin; Transcription, Genetic; Up-Regulation; Vasoconstrictor Agents | 2013 |
Defining uremic arterial functional abnormalities in patients recently started on haemodialysis: combined in vivo and ex vivo assessment.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Acetylcholine; Aged; Angiotensin II; Arteries; Bradykinin; Endothelin-1; Female; Humans; Kidney; Male; Middle Aged; Muscle Contraction; Muscle Relaxation; Myography; Nitroprusside; Norepinephrine; Pulse Wave Analysis; Renal Dialysis; Uremia; Vasoconstrictor Agents; Vasopressins | 2014 |
Pulmonary vascular and airway responses to systemic vasoconstrictors in anesthetized BALB/c mice.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Airway Resistance; Angiotensin II; Animals; Blood Pressure; Cardiac Output; Dose-Response Relationship, Drug; Endothelin-1; Mice; Mice, Inbred BALB C; Pulmonary Circulation; Thromboxane A2; Vascular Resistance; Vasoconstriction; Vasoconstrictor Agents; Vasopressins | 2015 |
Systemic vasoconstriction modulates the responses of pulmonary vasculature and airway to vasoconstrictors in anesthetized rats.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Angiotensin II; Animals; Blood Pressure; Bronchoconstriction; Endothelin-1; Lung; Male; Phenylephrine; Pulmonary Artery; Pulmonary Circulation; Rats; Rats, Sprague-Dawley; Vascular Resistance; Vasoconstriction; Vasoconstrictor Agents; Vasodilator Agents; Vasopressins | 2015 |
Facilitation by the renin-angiotensin system of cyclosporine-evoked hypertension in rats: Role of arterial baroreflexes and vasoreactivity.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Acetylcholine; Angiotensin II; Animals; Aorta; Atrasentan; Baroreflex; Blood Pressure; Captopril; Cyclosporine; Hypertension; Indomethacin; Losartan; Male; Naphthalenes; Nitric Oxide Synthase Type III; Nitroprusside; Oligopeptides; Phenylephrine; Piperidines; Propionates; Pyrrolidines; Rats; Renin-Angiotensin System; Vasoconstriction; Vasodilation | 2016 |